Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
Drug makers are sick and tired of coming under attack for high prices.
The Geisinger Health Plan, run by one of the nation’s top-rated health care organizations, foresees medical costs increasing next year by 7.5 percent for people buying insurance under the Affordable Care Act.
As health care consolidation accelerates nationwide, a new study shows that hospital prices in two of California’s largest health systems were 25 percent higher than at other hospitals around the state.
Five blood tests were performed in March at Torrance Memorial Medical Center. The hospital charged the patient’s insurer, Blue Shield of California, $408. The patient was responsible for paying $269.42.
Obama administration officials want to limit use of short-term health insurance in the United States to periods of three months or less.
The Obama administration is seeking to limit short-term health policies that include features largely banned under the Affordable Care Act, a proposal that could crimp a profitable and growing business for some insurers.
The state Senate on Wednesday took action to shine a light on skyrocketing prices for many prescription drugs, approving a bill that requires drug manufacturers to provide 60-days notice to purchasers if the cost is going to be increased by more than 10%.
Cancer drug costs have gone up 72 percent over the last five years, to about $15.9 billion. It’s one sobering reality oncologists are facing at one of their big annual meetings this week in Chicago.
The low-cost silver category of health plans on public exchanges appears to be the best refuge for Americans buying subsidized coverage under the Affordable Care Act, according to new analyses.
Anthem Inc. Chief Executive Joseph R. Swedish acknowledged “dynamic tension” with Cigna Corp. over their $48 billion pending merger, but said the health insurers had resolved differences and are on track to receive regulatory approval.